HealthSouth (HLS) Tops Q3 EPS by 4c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts HLS Hot Sheet
Financial Fact:
Less: Net income attributable to noncontrolling interests: -16.4M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
HealthSouth (NYSE: HLS) reported Q3 EPS of $0.53, $0.04 better than the analyst estimate of $0.49. Revenue for the quarter came in at $596.9 million versus the consensus estimate of $595.3 million.
HealthSouth sees FY2014 EPS of $2.24-$2.27, versus prior guidance of $2.25-$2.31 and the consensus of $2.05. It sees full-year 2014 Adjusted EBITDA guidance in a range of $575 million to $580 million from a range of $570 million to $580 million.
For earnings history and earnings-related data on HealthSouth (HLS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- L.B. Foster (FSTR) Reports In-Line Q3 EPS ; Offers Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
